Abstract
A study was carried out at the Midlands State University during the month of September
2016, to compare the antibacterial properties of Elephantorrhiza elephantine (Muzezapasi)
and Zanthoxylum chalybeum (Mukundanyoka), against those of the commercial drug
Azithromycin on Escherichia coli. Plant extracts were purchased, sun dried and ground into
fine powders. Azithromycin tablets were also purchased. Escherichia coli bacteria were
isolated from the University toilets. Confirmatory tests were used to verify Escherichia coli.
The three treatment drugs were then prepared into percentage solutions of 1%, 5%, 10%,
25% and 40% for E. elephantine and Z. chalybeum alone. A control was also prepared with
sterile distilled water. Filter paper discs of a diameter of 6mm were prepared and embedded
with the treatment drug percentage solution. Mueller hinton agar was inoculated with E.coli
and the treated filter paper discs were placed on the media and incubated for 18 hours at
37°C. Zones of inhibition (ZOI) were measured in millimetres. Comparisons on the
effectiveness of the drugs were then done and the results showed that the standard drug
Azithromycin was the most effective. Azithromycin had the lowest inhibitory effect of 12mm
at 1% concentration and a highest inhibitory effect of 27mm at 25%. Its general inhibitory
effect increased by an average of 15mm from 1% to 25%. Azithromycin’s most significant
increase was 10mm between 1% and 5%. Elephantorrhiza elephantine was more effective
than Zanthoxylum chalybeum at lower percentage concentrations as it showed some
inhibitory effect at 1% and 5% of 7mm and 8mm respectively and Zanthoxylum chalybeum
showed no inhibitory effect at all at the two lowest concentrations. Elephantorrhiza
elephantine had an average total inhibitory effect of 15mm. Its most significant inhibitory
effect occurred between 25% and 40% at 7mm zone of inhibition diameter. Zanthoxylum
chalybeum inhibition effect started at 10% concentration and its most significant increase was
between 25% and 40% at 8mm zone of inhibition diameter, which was similar to that of
Elephantorrhiza elephantine. Elephantorrhiza elephantine and Zanthoxylum chalybeum had
the same average effectiveness of 8mm at 25% concentration. The results concluded that the
commercial drug is greatly more effective than the unstandardized plant treatments, meaning
that its dosage must be less than that of the plant drugs. Azithromycin therefore can have
different dosages starting from below 1% because its 1% concentration has significant
antibacterial effectiveness. The two plants Elephantorrhiza elephantine and Zanthoxylum
chalybeum have an insignificant difference in effectiveness maybe due to differences in
active ingredients and mode of action on bacteria, and so their dosages may be the same and
should be in concentrations higher than 25% as their effectiveness is significant from that
point going to higher concentrations.
Mavindidze, V (2021). A comparative study of antibacterial properties of Elephantorrhiza elephantine (Muzezapasi) and Zanthoxylum chalybeum (Mukundanyoka) against those of commercial drug Azithromycin on Escherich. Afribary. Retrieved from https://afribary.com/works/a-comparative-study-of-antibacterial-properties-of-elephantorrhiza-elephantine-muzezapasi-and-zanthoxylum-chalybeum-mukundanyoka-against-those-of-commercial-drug-azithromycin-on-escherichia-c
Mavindidze, Varaidzo "A comparative study of antibacterial properties of Elephantorrhiza elephantine (Muzezapasi) and Zanthoxylum chalybeum (Mukundanyoka) against those of commercial drug Azithromycin on Escherich" Afribary. Afribary, 04 May. 2021, https://afribary.com/works/a-comparative-study-of-antibacterial-properties-of-elephantorrhiza-elephantine-muzezapasi-and-zanthoxylum-chalybeum-mukundanyoka-against-those-of-commercial-drug-azithromycin-on-escherichia-c. Accessed 22 Nov. 2024.
Mavindidze, Varaidzo . "A comparative study of antibacterial properties of Elephantorrhiza elephantine (Muzezapasi) and Zanthoxylum chalybeum (Mukundanyoka) against those of commercial drug Azithromycin on Escherich". Afribary, Afribary, 04 May. 2021. Web. 22 Nov. 2024. < https://afribary.com/works/a-comparative-study-of-antibacterial-properties-of-elephantorrhiza-elephantine-muzezapasi-and-zanthoxylum-chalybeum-mukundanyoka-against-those-of-commercial-drug-azithromycin-on-escherichia-c >.
Mavindidze, Varaidzo . "A comparative study of antibacterial properties of Elephantorrhiza elephantine (Muzezapasi) and Zanthoxylum chalybeum (Mukundanyoka) against those of commercial drug Azithromycin on Escherich" Afribary (2021). Accessed November 22, 2024. https://afribary.com/works/a-comparative-study-of-antibacterial-properties-of-elephantorrhiza-elephantine-muzezapasi-and-zanthoxylum-chalybeum-mukundanyoka-against-those-of-commercial-drug-azithromycin-on-escherichia-c